Masked inefficacy of arterial hypertension treatment: prevalence and predictors

Aim. To assess the prevalence of masked inefficacy of arterial hypertension treatment (AH MTI) and its predictors in various clinical groups and for various blood pressure (BP) control strategies, in order to evaluate the true effectiveness of antihypertensive therapy (AHT). Material and methods. AH...

Full description

Saved in:
Bibliographic Details
Main Authors: M. I. Smirnova, R. G. Oganov, M. V. Gorbunov, A. D. Deev, G. F. Andreeva
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2011-12-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1952
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839578030321696768
author M. I. Smirnova
R. G. Oganov
M. V. Gorbunov
A. D. Deev
G. F. Andreeva
author_facet M. I. Smirnova
R. G. Oganov
M. V. Gorbunov
A. D. Deev
G. F. Andreeva
author_sort M. I. Smirnova
collection DOAJ
description Aim. To assess the prevalence of masked inefficacy of arterial hypertension treatment (AH MTI) and its predictors in various clinical groups and for various blood pressure (BP) control strategies, in order to evaluate the true effectiveness of antihypertensive therapy (AHT). Material and methods. AHT effectiveness was assessed in two groups of the patients with Stage I-II AH (n=219 and n=39), by comparing the ratios of clinical (cl) to ambulatory (a) BP parameters. AH MTI was defined as elevated aBP and target clBP levels during AHT. The potential predictors of AH MTI included gender, age, body mass index (BMI), anamnestic data, frequency of the clinical visits to measure BP, quality of life (QoL) parameters (GWBQ questionnaire), circadian BP profile, orthostatic BP, and ECG signs of left ventricular hypertrophy (LVH). Results. AH MTI prevalence in Groups I and II was 11,0-15,7 % and 22,6-58,1 %, respectively, depending on the definition used. The groups were significantly different in terms of age, BMI, and QoL questionnaire III and VI domains. According to the regression analysis results, in Group I AH MTI was associated with QoL questionnaire II, V, and VI domains, baseline parameters of 24-hour BP monitoring, 24-hour systolic BP (SBP) variability, minimal daytime levels of mean BP, and metoprolol and atenolol therapy. In Group II, AH MTI was predicted by age, BMI, previously administered AHT, alcohol consumption, orthostatic SBP levels, Sokolow-Lyon index, Cornell voltage and Cornell product, Gubner index, and QoL questionnaire I, IV, and VI domains. Conclusion. AH MTI prevalence is associated with some baseline characteristics of the patients and the character of AHT. Due to regression to the mean, AH MTI prevalence could increase substantially when clBP parameters are measured more often.
format Article
id doaj-art-b99bead3ae8045d3849e7432dfa586be
institution Matheson Library
issn 1728-8800
2619-0125
language Russian
publishDate 2011-12-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-b99bead3ae8045d3849e7432dfa586be2025-08-04T12:50:17Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252011-12-01106111710.15829/1728-8800-2011-6-11-171664Masked inefficacy of arterial hypertension treatment: prevalence and predictorsM. I. Smirnova0R. G. Oganov1M. V. Gorbunov2A. D. Deev3G. F. Andreeva4State Research Centre for Preventive MedicineState Research Centre for Preventive MedicineState Research Centre for Preventive MedicineState Research Centre for Preventive MedicineState Research Centre for Preventive MedicineAim. To assess the prevalence of masked inefficacy of arterial hypertension treatment (AH MTI) and its predictors in various clinical groups and for various blood pressure (BP) control strategies, in order to evaluate the true effectiveness of antihypertensive therapy (AHT). Material and methods. AHT effectiveness was assessed in two groups of the patients with Stage I-II AH (n=219 and n=39), by comparing the ratios of clinical (cl) to ambulatory (a) BP parameters. AH MTI was defined as elevated aBP and target clBP levels during AHT. The potential predictors of AH MTI included gender, age, body mass index (BMI), anamnestic data, frequency of the clinical visits to measure BP, quality of life (QoL) parameters (GWBQ questionnaire), circadian BP profile, orthostatic BP, and ECG signs of left ventricular hypertrophy (LVH). Results. AH MTI prevalence in Groups I and II was 11,0-15,7 % and 22,6-58,1 %, respectively, depending on the definition used. The groups were significantly different in terms of age, BMI, and QoL questionnaire III and VI domains. According to the regression analysis results, in Group I AH MTI was associated with QoL questionnaire II, V, and VI domains, baseline parameters of 24-hour BP monitoring, 24-hour systolic BP (SBP) variability, minimal daytime levels of mean BP, and metoprolol and atenolol therapy. In Group II, AH MTI was predicted by age, BMI, previously administered AHT, alcohol consumption, orthostatic SBP levels, Sokolow-Lyon index, Cornell voltage and Cornell product, Gubner index, and QoL questionnaire I, IV, and VI domains. Conclusion. AH MTI prevalence is associated with some baseline characteristics of the patients and the character of AHT. Due to regression to the mean, AH MTI prevalence could increase substantially when clBP parameters are measured more often.https://cardiovascular.elpub.ru/jour/article/view/1952arterial hypertensionmasked arterial hypertension24-hour blood pressure monitoringantihypertensive therapypredictors
spellingShingle M. I. Smirnova
R. G. Oganov
M. V. Gorbunov
A. D. Deev
G. F. Andreeva
Masked inefficacy of arterial hypertension treatment: prevalence and predictors
Кардиоваскулярная терапия и профилактика
arterial hypertension
masked arterial hypertension
24-hour blood pressure monitoring
antihypertensive therapy
predictors
title Masked inefficacy of arterial hypertension treatment: prevalence and predictors
title_full Masked inefficacy of arterial hypertension treatment: prevalence and predictors
title_fullStr Masked inefficacy of arterial hypertension treatment: prevalence and predictors
title_full_unstemmed Masked inefficacy of arterial hypertension treatment: prevalence and predictors
title_short Masked inefficacy of arterial hypertension treatment: prevalence and predictors
title_sort masked inefficacy of arterial hypertension treatment prevalence and predictors
topic arterial hypertension
masked arterial hypertension
24-hour blood pressure monitoring
antihypertensive therapy
predictors
url https://cardiovascular.elpub.ru/jour/article/view/1952
work_keys_str_mv AT mismirnova maskedinefficacyofarterialhypertensiontreatmentprevalenceandpredictors
AT rgoganov maskedinefficacyofarterialhypertensiontreatmentprevalenceandpredictors
AT mvgorbunov maskedinefficacyofarterialhypertensiontreatmentprevalenceandpredictors
AT addeev maskedinefficacyofarterialhypertensiontreatmentprevalenceandpredictors
AT gfandreeva maskedinefficacyofarterialhypertensiontreatmentprevalenceandpredictors